Concept and benchmarks for assessing narrow-sense validity of genetic risk score values | |
Yu, Hongjie; Shi, Zhuqing; Wu, Yishuo; Wang, Chi-Hsiung; Lin, Xiaoling; Perschon, Chelsea; Isaacs, William B.; Helfand, Brian T.; Zheng, S. Lilly; Duggan, David | |
刊名 | PROSTATE |
2019 | |
卷号 | 79期号:10 |
关键词 | clinical validity genetic risk score (GRS) prostate cancer (PCa) |
ISSN号 | 0270-4137 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3596152 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Yu, Hongjie,Shi, Zhuqing,Wu, Yishuo,et al. Concept and benchmarks for assessing narrow-sense validity of genetic risk score values[J]. PROSTATE,2019,79(10). |
APA | Yu, Hongjie.,Shi, Zhuqing.,Wu, Yishuo.,Wang, Chi-Hsiung.,Lin, Xiaoling.,...&Xu, Jianfeng.(2019).Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.PROSTATE,79(10). |
MLA | Yu, Hongjie,et al."Concept and benchmarks for assessing narrow-sense validity of genetic risk score values".PROSTATE 79.10(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论